title: Downregulation of leukocyte migration after treatment with CCR5 antagonist maraviroc.
authors.forename: Raffaella
authors.initials: R
authors.lastname: Rossi
authors.forename: Miriam
authors.initials: M
authors.lastname: Lichtner
authors.forename: Ilaria
authors.initials: I
authors.lastname: Sauzullo
authors.forename: Fabio
authors.initials: F
authors.lastname: Mengoni
authors.forename: Raffaella
authors.initials: R
authors.lastname: Marocco
authors.forename: Anna Paola
authors.initials: AP
authors.lastname: Massetti
authors.forename: Claudio Maria
authors.initials: CM
authors.lastname: Mastroianni
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Vullo
mesh_terms: D019380:Anti-HIV Agents / Q000008:administration & dosage*; D054441:Cell Migration Assays, Leukocyte; D002465:Cell Movement / Q000187:drug effects*; D003510:Cyclohexanes / Q000008:administration & dosage*; D015536:Down-Regulation; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology*; D000077592:Maraviroc; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D019380:Anti-HIV Agents; D003510:Cyclohexanes; D007155:Immunologic Factors; D014230:Triazoles; D000077592:Maraviroc